Bio-Techne stock was surging Wednesday after the biotechnology company reported better fiscal third-quarter financial results ...
The clinical-stage biotech company received great news from the FDA.
Neurocrine stock rose Wednesday after the leading biotech topped Wall Street's sales expectations and wrapped a key ...
By Chris Wack MAIA Biotechnology shares hit their 52-week high Monday after it said that independent director Stan Smith made an individual purchase ...